Cargando…

Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach

Metformin is an orally effective insulin-sensitizing drug widely prescribed for treating type 2 diabetes mellitus (T2DM). Metformin has been reported to alter lipid metabolism. However, the molecular mechanisms behind its impact on lipid metabolism remain partially explored and understood. In the cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahabiyeh, Lina A., Mujammami, Muhammad, AlMalki, Reem H., Arafat, Tawfiq, Benabdelkamel, Hicham, Alfadda, Assim A., Abdel Rahman, Anas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569788/ https://www.ncbi.nlm.nih.gov/pubmed/36232780 http://dx.doi.org/10.3390/ijms231911478

Ejemplares similares

A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
por: Dahabiyeh, Lina A., et al.
Publicado: (2021)

The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
por: Jaber, Malak A., et al.
Publicado: (2022)

Metabolomic profile of patients on levothyroxine treatment for hypothyroidism
por: Benabdelkamel, Hicham, et al.
Publicado: (2023)

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
por: Alshahrani, Awad, et al.
Publicado: (2023)

Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
por: Aleidi, Shereen M., et al.
Publicado: (2021)

Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells
por: Alwehaibi, Moudi A., et al.
Publicado: (2023)

Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus
por: Mujammami, Muhammad, et al.
Publicado: (2022)

Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
por: Al-Ansari, Mysoon M., et al.
Publicado: (2021)

Obesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
por: Masood, Afshan, et al.
Publicado: (2018)

Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment
por: Masood, Afshan, et al.
Publicado: (2020)

Proteomics Profiling of the Urine of Patients with Hyperthyroidism after Anti-Thyroid Treatment
por: Benabdelkamel, Hicham, et al.
Publicado: (2021)

Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis
por: Benabdelkamel, Hicham, et al.
Publicado: (2020)

Exploring Cardio-Metabolic Effects of Liraglutide in Patients With Type 2 Diabetes Through a Proteomic Approach
por: Ekhzaimy, Aishah Ali, et al.
Publicado: (2021)

A Proteomics Based Approach Reveals Differential Regulation of Visceral Adipose Tissue Proteins between Metabolically Healthy and Unhealthy Obese Patients
por: Alfadda, Assim A., et al.
Publicado: (2017)

Differences in the Plasma Proteome of Patients with Hypothyroidism before and after Thyroid Hormone Replacement: A Proteomic Analysis
por: Alfadda, Assim A., et al.
Publicado: (2018)

A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients
por: Benabdelkamel, Hicham, et al.
Publicado: (2019)

Identification of Protein Changes in the Urine of Hypothyroid Patients Treated with Thyroxine Using Proteomics Approach
por: Masood, Afshan, et al.
Publicado: (2021)

Proteomic profiling of thyroid tissue in patients with obesity and benign diffuse goiter
por: Benabdelkamel, Hicham, et al.
Publicado: (2022)

Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation
por: Nedjadi, Taoufik, et al.
Publicado: (2021)

Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment
por: Ekhzaimy, Aishah A, et al.
Publicado: (2022)

Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer
por: Akkour, Khalid, et al.
Publicado: (2022)

Proteomic Profiling Reveals Cytotoxic Mechanisms of Action and Adaptive Mechanisms of Resistance in Porphyromonas gingivalis: Treatment with Juglans regia and Melaleuca alternifolia
por: Mohammed, Afrah E., et al.
Publicado: (2023)

Low Circulating Free Triiodothyronine Levels are Associated with the Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes
por: Siddiqui, Khalid, et al.
Publicado: (2022)

Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study
por: Siddiqui, Khalid, et al.
Publicado: (2023)

Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment
por: Rafiullah, Mohamed, et al.
Publicado: (2023)

Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects
por: Alfadda, Assim A.
Publicado: (2014)

Antimicrobial Mechanism and Identification of the Proteins Mediated by Extracts from Asphaltum punjabianum and Myrtus communis
por: Aabed, Kawther, et al.
Publicado: (2020)

A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns
por: Sebaa, Rajaa, et al.
Publicado: (2023)

The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study
por: Siddiqui, Khalid, et al.
Publicado: (2023)

Comparative Analysis of Milk Fat Globular Membrane (MFGM) Proteome between Saudi Arabia Camelus dromedary Safra and Wadha Breeds
por: Sabha, Bassam H., et al.
Publicado: (2020)

Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
por: Siddiqui, Khalid, et al.
Publicado: (2020)

Proteomic Profiling Comparing the Effects of Different Heat Treatments on Camel (Camelus dromedarius) Milk Whey Proteins
por: Benabdelkamel, Hicham, et al.
Publicado: (2017)

Reactive Oxygen Species in Health and Disease
por: Alfadda, Assim A., et al.
Publicado: (2012)

Label-free quantitative proteomics analysis for type 2 diabetes mellitus early diagnostic marker discovery using data-independent acquisition mass spectrometry (DIA-MS)
por: Nimer, Refat M., et al.
Publicado: (2023)

Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients
por: Alasmari, Fawaz, et al.
Publicado: (2021)

Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes
por: Alshammari, Nawaf A, et al.
Publicado: (2022)

Diet and Nutrition for Body Weight Management
por: Alfadda, Assim A., et al.
Publicado: (2019)

Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases
por: Matthiesen, Rune, et al.
Publicado: (2021)

Shotgun lipidomics and mass spectrometry imaging unveil diversity and dynamics in Gammarus fossarum lipid composition
por: Fu, Tingting, et al.
Publicado: (2021)

Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_998mcnqrtrpba0tp2p3dton0ks